Free Trial

INVO Bioscience Q1 2024 Earnings Report

INVO Bioscience logo
$0.46 -0.01 (-2.81%)
As of 01/22/2025

INVO Bioscience EPS Results

Actual EPS
-$0.42
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

INVO Bioscience Revenue Results

Actual Revenue
$1.58 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

INVO Bioscience Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

INVO Bioscience Earnings Headlines

NAYA Biosciences To Raise $9.5 Mln Through Public Offering Of Units
NAYA Biosciences to present insights into mode of action of NY-303
Your chance to get on the next “60-Second Trade”
Even retirees are being forced back to work just to keep up. And if you're waiting for help from the Fed or government... Well, you might be waiting a very long time. But Roger Scott has uncovered something interesting... What if there was a way to fight back against inflation? A simple method you could use right from your phone...
NAYA Biosciences Inc (INVO)
See More INVO Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Bioscience and other key companies, straight to your email.

About INVO Bioscience

INVO Bioscience (NASDAQ:INVO), together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

View INVO Bioscience Profile

More Earnings Resources from MarketBeat